Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

CG Oncology has the lowest figure of the 24 biotech companies ranked by cash on hand, at A$48.6M, followed by Adaptive Biotechnologies (A$105.4M) and ImmunityBio (A$132M). Figures as of 19 Nov 2026, 01:07 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CG OncologyA$48.6M
Median
A$647.3M
Combined market value
A$1.25T
Countries
5

Market values as of .

All countries
All sectors
Biotech
AUD
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareA$48.6MA$10.7BA$119.56 1.34% up 85% up United States
2Adaptive BiotechnologiesADPT · Health CareA$105.4MA$6.9BA$42.53 0.11% down 88% up United States
3ImmunityBioIBRX · Health CareA$132MA$10.7BA$10.01 7.03% up 193% up United States
4Halozyme TherapeuticsHALO · Health CareA$200MA$16.3BA$143.17 0.18% down 37% up United States
5VaxcytePCVX · Health CareA$260MA$13.8BA$87.46 1.48% down 22% up United States
6Twist BioscienceTWST · Health CareA$273.6MA$11.9BA$173.89 3.88% up 340% up United States
7Kodiak SciencesKOD · Health CareA$313.6MA$9.6BA$146.18 1.04% up 396% up United States
8Bio-TechneTECH · Health CareA$395.6MA$17.1BA$108.72 0.17% up 26% up United States
9Scholar Rock HoldingSRRK · Health CareA$483.5MA$8.8BA$71.74 6.48% up 14% up United States
10CRISPR TherapeuticsCRSP · Health CareA$519.4MA$5.8BA$60.06 0.10% up 21% down Switzerland
11Kymera TherapeuticsKYMR · Health CareA$533.6MA$15.5BA$181.03 0.32% down 87% up United States
12Revolution MedicinesRVMD · Health CareA$573.5MA$51.7BA$238.85 1.76% down 131% up United States
13ExelixisEXEL · Health CareA$721.1MA$24.9BA$102.06 0.31% down 63% up United States
14Krystal BiotechKRYS · Health CareA$741.7MA$14BA$471.28 5.62% up 46% up United States
15RepligenRGEN · Health CareA$845.9MA$16.5BA$258.06 6.47% up 5% up United States
16Neurocrine BiosciencesNBIX · Health CareA$1.1BA$24.6BA$243.39 1.84% down 20% up United States
17QiagenQGEN · Health CareA$1.3BA$15.3BA$74.07 0.38% down 12% up Netherlands
18ImmunovantIMVT · Health CareA$1.3BA$10.3BA$49.57 0.12% down 43% up United States
19ModernaMRNA · Health CareA$3.9BA$119BA$294.10 4.84% down 755% up United States
20BiogenBIIB · Health CareA$4.5BA$55.5BA$375.73 0.25% up 49% up United States
21argenxARGX · Health CareA$5.2BA$88.5BA$1,406.70 0.66% down 4% up Belgium
22Gilead SciencesGILD · Health CareA$11.3BA$313.2BA$252.54 0.75% down 33% up United States
23BioNTechBNTX · Health CareA$12.7BA$30.9BA$124.43 1.89% down 16% down Germany
24AmgenAMGN · Health CareA$13.6BA$358.8BA$663.39 3.07% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.4945 AUD).

Questions and answers

Which biotech companies have the lowest cash on hand?

CG Oncology (A$48.6M), Adaptive Biotechnologies (A$105.4M) and ImmunityBio (A$132M) have the lowest cash on hand of the 24 biotech companies ranked here as of 19 Nov 2026, 01:07 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of A$1.25T as of 19 Nov 2026, 01:07 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.